# Observational hematologic cancer studies: 97 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 97 trials that are observational for hematologic cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational hematologic cancer studies: 97 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 4 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/hematologic-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 97
- Recruiting or not yet: 97
- Read on: November 19, 2026

## Trials

The 25 newest of 97, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 17, 2026 | NCT07943039 | Safety and Efficacy of pALG in Conditioning Regimen for HLA-Matched Sibling HSCT in Patients With SAA or Hematological Malignancies (... | Institute of Hematology & Blood Diseases Hospital, China | Observational | Not yet recruiting | Severe Aplastic Anemia (SAA), Hematologic Malignancies | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07943039) |
| November 16, 2026 | NCT07939139 | Shadow-Mode Evaluation of an AI Assistant for Multidisciplinary Tumor Boards | Technical University of Munich | Observational | Recruiting | Hematologic Neoplasms, Sarcoma, Bone Neoplasms, Head and Neck Neoplasms | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939139) |
| October 28, 2026 | NCT07900542 | Middle East Study of Infections in Patients With Hematological Malignancies | Hamad Medical Corporation | Observational | Recruiting | Hematological Malignancy, Hematopoetic Stem Cell Transplantation, Bloodstream Infection | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900542) |
| October 7, 2026 | NCT07864467 | BHF-COLLATE: UK Prospective, Multi-centre, Observational, Cardio-oncology Anthracycline Registry | South Tees Hospitals NHS Foundation Trust | Observational | Not yet recruiting | Cancer and / or Hematological Malignancy, Anthracycline-induced Cardiotoxicity | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07864467) |
| October 6, 2026 | NCT07861971 | Feasibility Study of a Sports-Inspired Onco-Coaching Progranm for Young Adults i Cancer Remission | Institut Paoli-Calmettes | Observational | Recruiting | Solid and Hematologic Cancer | 19 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861971) |
| September 25, 2026 | NCT07842679 | Cognitive Impairment in Older Adults With Hematologic Malignancies | Assiut University | Observational | Not yet recruiting | Cognitive Impairment, Hematologic Malignancies, Chemotherapy Effect | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07842679) |
| September 17, 2026 | NCT07825714 | Metagenomic Sequencing Across the Infectious Disease Risk and Care Continuum | Karius, Inc. | Observational | Not yet recruiting | Infectious Diseases, Immunocompromised Host, Opportunistic Infections | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07825714) |
| September 3, 2026 | NCT07802015 | Home-based Intravenous Cytarabine Treatment for Acute Myeloid Leukemia: a National Danish Study of Feasibility, Costs, and Implementation | Zealand University Hospital | Observational | Not yet recruiting | Hematologic Cancer, Acute Myeloid Leukaemia (AML), Hospital At Home, Home-based Chemotherapy | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07802015) |
| August 25, 2026 | NCT07785505 | Musculoskeletal Ultrasound in Patients With Hematologic Malignancies | Assiut University | Observational | Not yet recruiting | Hematologic Neoplasms, Leukemia, Lymphoma, Multiple Myeloma, Musculoskeletal Diseases | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07785505) |
| August 13, 2026 | NCT07763184 | mNGS for IFD in Patients With Hematological Malignancies | Nanfang Hospital, Southern Medical University | Observational | Not yet recruiting | Hematological Malignancies, Invasive Fungal Disease | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07763184) |
| August 13, 2026 | NCT07763054 | Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients | Haikou Affiliated Hospital of Central South University Xiangya School of Medicine | Observational | Recruiting | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Lymphoma, Multiple Myeloma, Chronic... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07763054) |
| August 10, 2026 | NCT07756034 | Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer | Tempus AI | Observational | Recruiting | Cancer, Solid Tumor Cancer, Pediatric Acute Myeloid Leukemia, Hematologic Malignancies | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07756034) |
| August 4, 2026 | NCT07743476 | Bone Marrow Imaging and Clinical Outcomes Across Hematologic, Oncologic, and Other Relevant Conditions | M.D. Anderson Cancer Center | Observational | Recruiting | Hematologic, Oncologic, Bone Marrow | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07743476) |
| July 20, 2026 | NCT07714044 | Rutgers University Study of the Genetics of Blood Cancers | Rutgers, The State University of New Jersey | Observational | Recruiting | Blood Cancers, Blood Cancer, Leukemia, Lymphoma, Myeloma, Hematologic Cancer, Hematologic Malignancies, Hematologic... | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07714044) |
| July 17, 2026 | NCT07711327 | Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy | Sponsor not shown (see the record) | Observational | Not yet recruiting | Atrial Fibrillation (AF), Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Mantle Cell Lymphoma, Marginal... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07711327) |
| July 14, 2026 | NCT07703644 | Ceftazidime-Avibactam PK/PD and Resistance in Hematology Patients | Sponsor not shown (see the record) | Observational | Not yet recruiting | Hematologic Neoplasms, Gram-Negative Bacterial Infections, Pseudomonas Aeruginosa Infection, Klebsiella Pneumoniae... | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07703644) |
| July 8, 2026 | NCT07691008 | Wearable Data for Personalized Prognostication in Cancer: A Registry Protocol | City of Hope Medical Center | Observational | Not yet recruiting | Hematopoietic Neoplasm, Malignant Solid Neoplasm, Lymphatic System Neoplasm, Hematopoietic and Lymphatic System Neoplasm | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07691008) |
| June 23, 2026 | NCT07662382 | Cousin vs. Sibling Donors in Haplo-HSCT | The First Affiliated Hospital of Soochow University | Observational | Not yet recruiting | Hematopoietic Malignancies, Haploidentical Hematopoietic Stem Cell Transplantation, Donor | 1,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07662382) |
| June 17, 2026 | NCT07653672 | Role of Viscoelastometric Testing in the Development and Validation of a Clinical-biological Score for Predicting Bleeding in Patients With... | Centre Hospitalier Annecy Genevois | Observational | Recruiting | Thrombocytopenia, Platelet Transfusion, Haemorrhage, Hematologic Malignancies | 410 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07653672) |
| June 8, 2026 | NCT07634263 | Why Patients Decline or Are Being Deemed Ineligible to Receive Home-based Treatment: a Mixed Methods Study | Odense University Hospital | Observational | Not yet recruiting | Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma, Multiple Myeloma Progression, Multiple... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07634263) |
| June 2, 2026 | NCT07621289 | Risk Prediction Scores for Cardiotoxicity in Cancer Patients Treated With Cardiotoxic Anticancer Therapies in Europe | University Hospital, Caen | Observational | Not yet recruiting | Cancer, Anticancer Treatment, Cardiovascular Disease Risk Factor, Cardiovascular Diseases, Hematological Malignancies | 10,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07621289) |
| May 27, 2026 | NCT07609485 | Identifying Cellular and Molecular Determinants of Efficacy and Resistance in Patients Undergoing CAR-T Therapy | University Hospital, Lille | Observational | Recruiting | Cancer, Hematologic Malignancy | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07609485) |
| March 11, 2026 | NCT07463976 | variaTIon in Referral Thresholds in the Chronic Lymphocytic LeukaEmia Pathway | The Royal Wolverhampton Hospitals NHS Trust | Observational | Not yet recruiting | Chronic Lymphocytic Leukemia, Haematological Malignancy | 130 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07463976) |
| January 23, 2026 | NCT07362225 | MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative... | MPN Research Foundation | Observational | Recruiting | Polycythemia Vera, ET (Essential Thrombocythemia), Polycythemia Vera (PV), Essential Thrombocythemia (ET), Primary... | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07362225) |
| December 26, 2025 | NCT07305090 | Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease... | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Observational | Recruiting | Blood Cancer | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07305090) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| M.D. Anderson Cancer Center | 10 |
| Assiut University | 4 |
| St. Jude Children's Research Hospital | 3 |
| Institute of Hematology & Blood Diseases Hospital, China | 3 |
| Odense University Hospital | 2 |
| Center for International Blood and Marrow Transplant Research | 2 |
| Technical University of Munich | 2 |
| Tempus AI | 2 |
| Dana-Farber Cancer Institute | 2 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2 |
| Munich Leukemia Laboratory | 2 |
| Mayo Clinic | 2 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Alliance for Clinical Trials in Oncology | 2 |
| University of California, San Francisco | 1 |
| University of Missouri-Columbia | 1 |
| Northside Hospital, Inc. | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Instituto de Investigación Biomédica de Salamanca | 1 |
| South Tees Hospitals NHS Foundation Trust | 1 |
| MPN Research Foundation | 1 |
| University Hospital, Clermont-Ferrand | 1 |
| Meir Medical Center | 1 |
| Azienda USL Reggio Emilia - IRCCS | 1 |
| The First Affiliated Hospital of Soochow University | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 43 |
| China | 10 |
| France | 8 |
| Germany | 6 |
| Italy | 5 |
| Denmark | 4 |
| Spain | 3 |
| United Kingdom | 3 |
| Egypt | 3 |
| Israel | 2 |
| Switzerland | 2 |
| Czechia | 1 |
| Greece | 1 |
| Lithuania | 1 |
| Hong Kong | 1 |
| Jordan | 1 |
| Oman | 1 |
| Qatar | 1 |
| Saudi Arabia | 1 |
| United Arab Emirates | 1 |
| Belgium | 1 |
| Hungary | 1 |
| Netherlands | 1 |
| Sweden | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Shipping collection companies in the United States](https://specstream.ai/data/businesses/shipping-collection-companies/united-states)
- [Salad bars in the United States](https://specstream.ai/data/businesses/salad-bars/united-states)
- [Records storage companies in the United States](https://specstream.ai/data/businesses/records-storage-companies/united-states)
- [Psychiatry practices in the United States](https://specstream.ai/data/businesses/psychiatry-practices/united-states)
- [Preschools in the United States](https://specstream.ai/data/businesses/preschools/united-states)
- [Pipe suppliers in the United States](https://specstream.ai/data/businesses/pipe-suppliers/united-states)
